Mirtazapine is not a narcotic. It is an antidepressant, specifically a tetracyclic antidepressant sometimes called a noradrenergic and specific serotonergic antidepressant (NaSSA). It carries no DEA scheduling, is not classified as a controlled substance, and is FDA-approved for treating major depressive disorder. The confusion likely stems from the fact that mirtazapine can cause noticeable sedation and drowsiness, effects people sometimes associate with narcotics.
Why Mirtazapine Gets Confused With Narcotics
The term “narcotic” in medical and legal contexts refers specifically to opioid analgesics, drugs like morphine that dull pain, alter consciousness, and carry a high risk of addiction. The DEA uses “narcotic” exclusively for opioid-type drugs. Mirtazapine doesn’t belong to this category at all.
What causes the confusion is mirtazapine’s sedating side effects. The drug strongly blocks histamine receptors in the brain, the same receptors targeted by drowsiness-inducing allergy medications. This produces a pronounced calming, sleepy effect, especially when you first start taking it. If you’ve been prescribed mirtazapine and felt heavily sedated or “knocked out,” it’s understandable to wonder whether you’re taking something stronger than a typical antidepressant. But that sedation comes from a completely different mechanism than what narcotics do.
How Mirtazapine Actually Works
Mirtazapine increases levels of two chemical messengers in the brain: serotonin and norepinephrine. It does this by blocking a specific type of receptor (called alpha-2 adrenergic receptors) that normally acts as a brake on the release of these chemicals. With that brake removed, more serotonin and norepinephrine become available, which over time helps lift depression.
The drug also blocks several types of serotonin receptors, which channels serotonin toward the specific receptor subtype responsible for its antidepressant effect. As a side benefit, blocking these other serotonin receptors reduces nausea and can ease anxiety. Meanwhile, the norepinephrine boost stimulates the sympathetic nervous system, which can increase overall activity and metabolism.
Narcotics, by contrast, work by binding to opioid receptors in the brain and spinal cord, directly suppressing pain signals and producing euphoria. Mirtazapine does not primarily target opioid receptors and does not produce the classic opioid “high.” One lab study published in the British Journal of Pharmacology found that mirtazapine can weakly activate one type of opioid receptor (the kappa receptor) at high concentrations, but this is not the mechanism responsible for its clinical effects and does not make it an opioid drug.
Controlled Substance Status
The Controlled Substances Act in the United States places drugs into five schedules based on their medical value, addiction risk, and potential for harm. Mirtazapine is not on any of these schedules. Its FDA-approved labeling explicitly states: “Mirtazapine tablets are not a controlled substance.”
In practical terms, this means your doctor can prescribe mirtazapine with a standard prescription. There’s no need for the special monitoring programs, prescription limits, or refill restrictions that apply to Schedule II through V drugs. You won’t encounter the same pharmacy hurdles you’d face with opioid painkillers or stimulants.
Sedation, Appetite, and Other Effects
Mirtazapine’s side effect profile is distinct from most other antidepressants, which is another reason people sometimes question what kind of drug it is. The most common effects include:
- Drowsiness and sedation: Often strongest at lower doses and during the first weeks of treatment. This comes from histamine receptor blocking, not opioid activity.
- Increased appetite and weight gain: Mirtazapine stimulates appetite significantly enough that it’s sometimes prescribed off-label for people who need to regain weight.
- Reduced nausea: The drug’s anti-nausea effect comes from blocking a specific serotonin receptor involved in vomiting.
- Anxiety relief: Some people notice a calming effect relatively quickly, before the full antidepressant benefits kick in.
These effects, particularly the heavy sedation and appetite changes, can feel dramatic and unfamiliar if you’ve only ever taken SSRIs like sertraline or fluoxetine. But they reflect mirtazapine’s unique receptor profile as an antidepressant, not any narcotic property.
Can Mirtazapine Be Abused or Cause Dependence?
While mirtazapine is not a controlled substance, it’s not entirely without risk in this area. Case reports and preliminary research have flagged occasional misuse, particularly at high doses where some users have reported hallucinogenic or delirium-like effects. A 2022 mouse study found that animals given mirtazapine at certain doses preferred it over water and showed drug-seeking behavior, along with memory impairment similar to patterns seen with known drugs of abuse.
Stopping mirtazapine abruptly can also cause withdrawal-like symptoms: rebound depression, insomnia, anxiety, restlessness, nausea, and vomiting. These discontinuation effects are common across many antidepressant classes and are not unique to mirtazapine. They also don’t indicate the same type of physical dependence that develops with opioids. Still, tapering off gradually rather than stopping cold turkey is the standard approach.
The overall abuse potential of mirtazapine is considered low enough that regulators have not placed it under controlled substance restrictions. But the existence of scattered reports means it’s worth being aware that the drug does have psychoactive properties beyond its intended antidepressant effect, particularly at higher-than-prescribed doses.
What the Box Warning Covers
Mirtazapine carries an FDA black box warning, but it has nothing to do with addiction or narcotic-like effects. The warning applies to all antidepressants and flags an increased risk of suicidal thinking and behavior in children, adolescents, and young adults under 25. This risk is highest during the first weeks of treatment or when doses change. It’s a standard warning across the antidepressant class, not something specific to mirtazapine’s pharmacology.